Ludwig, Kerstin U.
Schmithausen, Ricarda M. https://orcid.org/0000-0002-3736-8672
Li, David
Jacobs, Max L. https://orcid.org/0000-0001-5665-9339
Hollstein, Ronja
Blumenstock, Katja
Liebing, Jana
Słabicki, Mikołaj https://orcid.org/0000-0001-6317-9296
Ben-Shmuel, Amir
Israeli, Ofir
Weiss, Shay
Ebert, Thomas S.
Paran, Nir https://orcid.org/0000-0001-5143-9660
Rüdiger, Wibke
Wilbring, Gero https://orcid.org/0000-0002-5770-0054
Feldman, David
Lippke, Bärbel
Ishorst, Nina
Hochfeld, Lara M. https://orcid.org/0000-0002-2808-0693
Beins, Eva C. https://orcid.org/0000-0002-7779-0210
Kaltheuner, Ines H.
Schmitz, Maximilian
Wöhler, Aliona
Döhla, Manuel https://orcid.org/0000-0001-8029-5264
Sib, Esther
Jentzsch, Marius
Moench, Eva-Maria C.
Borrajo, Jacob D.
Strecker, Jonathan
Reinhardt, Julia
Cleary, Brian https://orcid.org/0000-0003-0825-7129
Geyer, Matthias
Hölzel, Michael
Macrae, Rhiannon https://orcid.org/0000-0002-7850-9056
Nöthen, Markus M.
Hoffmann, Per https://orcid.org/0000-0002-6573-983X
Exner, Martin
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Zhang, Feng https://orcid.org/0000-0003-0178-7995
Schmid-Burgk, Jonathan L. https://orcid.org/0000-0003-0988-2487
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LU-1944/3-1, EXC2151 – 390873048)
Howard Hughes Medical Institute
Bundesministerium für Bildung und Forschung (01KX2021)
Article History
Received: 20 October 2020
Accepted: 26 May 2021
First Online: 29 June 2021
Change Date: 18 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41587-022-01428-6
Competing interests
: K.U.L., D.L., F.Z. and J.S.-B. are inventors on patent applications filed by the Broad Institute and others related to this work with the specific aim of ensuring that this technology can be made rapidly available for research and deployment. F.Z. is a co-founder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies and Sherlock Biosciences. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. Since 1 August 2020, A.R. has been an employee of Genentech, a member of the Roche Group. P.H. and M.M.N. are scientific advisory board members of HMG Systems Bioengineering and receive salaries from Life & Brain. M.M.N. served on scientific advisory boards for the Lundbeck Foundation and Robert-Bosch-Stiftung, was reimbursed for travel expenses by Shire and holds shares in Life & Brain. J.D.B. is a co-founder of Coral Genomics and a scientific advisory board member of Alix Ventures.
Free to read: This content has been made available to all.